These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 2188399)
1. m-CPP: a tool for studying behavioural responses associated with 5-HT1c receptors. Curzon G; Kennett GA Trends Pharmacol Sci; 1990 May; 11(5):181-2. PubMed ID: 2188399 [No Abstract] [Full Text] [Related]
2. Modulation of the 5-HT1C receptor-mediated behavior by 5-HT2, but not 5-HT1A, receptor activation. Chojnacka-Wójcik E Pol J Pharmacol Pharm; 1992; 44(5):427-36. PubMed ID: 1363616 [TBL] [Abstract][Full Text] [Related]
3. Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635. Bagdy G; Graf M; Anheuer ZE; Modos EA; Kantor S Int J Neuropsychopharmacol; 2001 Dec; 4(4):399-408. PubMed ID: 11806866 [TBL] [Abstract][Full Text] [Related]
4. Discriminative stimulus effects of m-chlorophenylpiperazine as a model of the role of serotonin receptors in anxiety. Gatch MB Life Sci; 2003 Aug; 73(11):1347-67. PubMed ID: 12850497 [TBL] [Abstract][Full Text] [Related]
5. Supersensitized oral responses to a serotonin agonist in neonatal 6-OHDA-treated rats. Gong L; Kostrzewa RM Pharmacol Biochem Behav; 1992 Mar; 41(3):621-3. PubMed ID: 1584843 [TBL] [Abstract][Full Text] [Related]
6. Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors. Kennett GA; Curzon G Br J Pharmacol; 1988 May; 94(1):137-47. PubMed ID: 3401632 [TBL] [Abstract][Full Text] [Related]
7. Effect of 1-(m-chlorophenyl)piperazine and 1-(m-trifluoromethylphenyl)piperazine on locomotor activity. Lucki I; Ward HR; Frazer A J Pharmacol Exp Ther; 1989 Apr; 249(1):155-64. PubMed ID: 2709329 [TBL] [Abstract][Full Text] [Related]
8. Chronic treatment with meta-chlorophenylpiperazine (m-CPP) alters behavioral and cerebral metabolic responses to the serotonin agonists m-CPP and quipazine but not 8-hydroxy-2(di-N-propylamino)tetralin. Freo U; Holloway HW; Greig NH; Soncrant TT Psychopharmacology (Berl); 1992; 107(1):30-8. PubMed ID: 1534179 [TBL] [Abstract][Full Text] [Related]
9. 5-HT1A and 5-HT1C/1D receptor agonists produce reciprocal effects on male sexual behavior of rhesus monkeys. Pomerantz SM; Hepner BC; Wertz JM Eur J Pharmacol; 1993 Oct; 243(3):227-34. PubMed ID: 8276074 [TBL] [Abstract][Full Text] [Related]
10. Central serotoninmimetic action of phenylpiperazines. Maj J; Lewandowska A Pol J Pharmacol Pharm; 1980; 32(4):495-504. PubMed ID: 7255267 [TBL] [Abstract][Full Text] [Related]
11. Effects of various serotonin receptor subtype-selective antagonists alone and on m-chlorophenylpiperazine-induced neuroendocrine changes in rats. Aulakh CS; Hill JL; Murphy DL J Pharmacol Exp Ther; 1992 Nov; 263(2):588-95. PubMed ID: 1432690 [TBL] [Abstract][Full Text] [Related]
12. Behavioural evidence for functional interactions between 5-HT-receptor subtypes in rats and mice. Berendsen HH; Broekkamp CL Br J Pharmacol; 1990 Nov; 101(3):667-73. PubMed ID: 2150180 [TBL] [Abstract][Full Text] [Related]
13. Anxiogenic-like effect of serotonin(1B) receptor stimulation in the rat elevated plus-maze. Lin D; Parsons LH Pharmacol Biochem Behav; 2002 Apr; 71(4):581-7. PubMed ID: 11888549 [TBL] [Abstract][Full Text] [Related]
19. Further studies of the putative serotonin agonist, m-chlorophenylpiperazine: evidence for a serotonin receptor mediated mechanism of action in humans. Mueller EA; Murphy DL; Sunderland T Psychopharmacology (Berl); 1986; 89(3):388-91. PubMed ID: 3014595 [TBL] [Abstract][Full Text] [Related]
20. Chronic mianserin or eltoprazine treatment in rats: effects on the elevated plus-maze test and on limbic 5-HT2C receptor levels. Rocha B; Rigo M; Di Scala G; Sandner G; Hoyer D Eur J Pharmacol; 1994 Sep; 262(1-2):125-31. PubMed ID: 7813563 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]